Incidence and Characteristics of Delayed Inflammatory Reactions Secondary to Hyaluronic Acid Filler Injections: A Systematic Review With Meta-Analysis

Clicks: 80
ID: 327042
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 125 articles by views in Aesthetic Surgery Journal Open Forum

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Delayed inflammatory reactions (DIRs) are rare but increasingly relevant complications of hyaluronic acid (HA) fillers. Objectives To examine the incidence and characteristics of DIRs secondary to HA fillers for facial aesthetic indications. Methods We systematically reviewed studies published before 3 December 2024 from PUBMED and EMBASE, using a random effects meta-analysis model to compute pooled incidence rates of DIR with 95% confidence intervals (CI). Subgroup analyses were performed according to filler crosslinking technology. Case data were analyzed descriptively. Results The meta-analysis included 242 studies, and case data was supplemented from 71 additional reports. The pooled incidence of DIRs was 0.0005 (95% CI: 0.0002–0.0013) events per patient-years, equivalent to an event occurring for every 2000 patients with one year of follow-up. When analyzed by crosslinking technology, incidence rates per patient-year was 0.0044 (95% CI: 0.0006–0.0314) for SHAPE, 0.0022 (95% CI: 0.0011–0.0043) for Vycross, 0.0007 (95% CI: 0.0003–0.0017) for NASHA and 0.0006 (95% CI: 0.0002–0.0025) for HICE; several filler technologies, including CPM-based fillers, reported no incident DIR cases during follow-up. The median time to onset was 3 months (Range: 2 weeks to 12 years) and time to resolution was 2.9 months (Range: 1 day to 6 years). Common presentations included nodules, redness, swelling and induration. Management often involved hyaluronidase, corticosteroids and antibiotics. Conclusions DIRs are rare adverse events following aesthetic HA filler treatments, exhibiting varied times to onset and resolution. Incidence rates appear to vary by crosslinking technology, and awareness of potential differences can contribute to safe and natural outcomes.
Reference Key
openalex_W7204931991 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jimyung Seo, Jonathan Kadouch, Tatjana Pavicic, Niamh Corduff, Qin Li, Ada Trindade de Almeida, Clifton Ming Tay, Wei Qi Loh
Are you one of these authors? Claim your profile
Journal Aesthetic Surgery Journal Open Forum
Year 2026
DOI
10.1093/asjof/ojag165
URL
https://doi.org/10.1093/asjof/ojag165
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.